文献速递认知障碍与痴呆

轻度认知障碍患者认知恢复正常相关的临床病理因素

Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment.
PubMed 文献 · Neurology · 2022-03-21

本研究分析三个纵向队列(MCSA、ROSMAP、NACC),比较有或无认知恢复正常经历的轻度认知障碍(MCI)患者的临床病理特征。MCI恢复者在末次随访时保持认知正常的可能性更高(MCSA HR 3.31,ROSMAP HR 3.72,NACC HR 9.29),进展为痴呆的风险更低(MCSA HR 0.12,ROSMAP HR 0.41,NACC HR 0.29)。与未恢复者相比,恢复者皮层厚度和葡萄糖代谢保留更好,淀粉样蛋白水平较低但未达统计学显著,tau负荷无差异。

要点

  • MCI恢复者在末次随访时认知正常的可能性更高,进展为痴呆的风险更低。
  • 恢复者皮层厚度和葡萄糖代谢保留更好,淀粉样蛋白水平较低但未达统计学显著。
  • 恢复者与未恢复者之间tau负荷无差异。

核心结论

  • MCI恢复至正常认知可能归因于皮层结构和葡萄糖代谢的更好保留。

研究设计与样本

  • 分析三个纵向队列:Mayo Clinic Study of Aging(MCSA)、Religious Orders Study and Memory and Aging Project(ROSMAP)和National Alzheimer's Coordinating Center(NACC)。
  • 比较有或无认知恢复正常经历的MCI患者的人口学特征和临床结局。
  • 在MCSA中比较有多次MRI或PET影像信息的恢复者与未恢复者亚组的皮层厚度、葡萄糖代谢、淀粉样蛋白和tau负荷的纵向变化。

主要发现

  • MCSA中164例(56.4%)、ROSMAP中508例(66.8%)、NACC中280例(34.1%)个体经历MCI恢复至正常认知。
  • Cox比例风险回归模型显示,MCI恢复者在末次随访时认知正常的可能性增加:MCSA HR 3.31(95% CI 2.14-5.12),ROSMAP HR 3.72(95% CI 2.50-5.56),NACC HR 9.29(95% CI 6.45-13.40)。
  • MCI恢复者进展为痴呆的风险降低:MCSA HR 0.12(95% CI 0.05-0.29),ROSMAP HR 0.41(95% CI 0.32-0.53),NACC HR 0.29(95% CI 0.21-0.40)。
  • 与MCI未恢复者相比,恢复者皮层厚度保留更好(β = 0.082,p <0.001),葡萄糖代谢保留更好(β = 0.119,p = 0.001),淀粉样蛋白水平较低但未达统计学显著(β = -0.172,p = 0.090)。
  • 恢复者与未恢复者之间tau负荷无差异(β = 0.073,p = 0.24)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To identify clinicopathologic factors contributing to mild cognitive impairment (MCI) reversion to normal cognition. METHODS: We analyzed 3 longitudinal cohorts in this study: the Mayo Clinic Study of Aging (MCSA), the Religious Orders Study and Memory and Aging Project (ROSMAP), and the National Alzheimer's Coordinating Center (NACC). Demographic characteristics and clinical outcomes were compared between patients with MCI with or without an experience of reversion to normal cognition (referred to as reverters and nonreverters, respectively). We also compared longitudinal changes in cortical thickness, glucose metabolism, and amyloid and tau load in a subcohort of reverters and nonreverters in MCSA with MRI or PET imaging information from multiple visits. RESULTS: We identified 164 (56.4%) individuals in MCSA, 508 (66.8%) individuals in ROSMAP, and 280 (34.1%) individuals in NACC who experienced MCI reversion to normal cognition. Cox proportional hazards regression models showed that MCI reverters had an increased chance of being cognitively normal at the last visit in MCSA (HR 3.31, 95% CI 2.14-5.12), ROSMAP (HR 3.72, 95% CI 2.50-5.56), and NACC (HR 9.29, 95% CI 6.45-13.40) and a reduced risk of progression to dementia (HR 0.12, 95% CI 0.05-0.29 in MCSA; HR 0.41, 95% CI 0.32-0.53 in ROSMAP; and HR 0.29, 95% CI 0.21-0.40 in NACC). Compared with MCI nonreverters, reverters had better-preserved cortical thickness (β = 0.082, p <0.001) and glucose metabolism (β = 0.119, p = 0.001) and lower levels of amyloid, albeit statistically nonsignificant (β = -0.172, p = 0.090). However, no difference in tau load was found between reverters and nonreverters (β = 0.073, p = 0.24). DISCUSSION: MCI reversion to normal cognition is likely attributed to better-preserved cortical structure and glucose metabolism.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Li Z, Heckman MG, Kanekiyo T, et al. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022. PMID: 35314499. doi:10.1212/WNL.0000000000200387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。